Monthly Archives: February, 2018
Industry Reports
Stryker reports 2017 results and 2018 outlook
Stryker Corporation reported 2017 operating results for the fourth quarter and full year and 2018 outlook:
Fourth Quarter Highlights
Net sales grew 10.0% to $3.5...
Research Insight
Long-term protection against HIV : Gene therapy using CAR T cells
A UCLA-led research team has created blood-forming stem cells that can carry a gene that allows the body to produce cells that can detect...
Press Releases
Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): A multicentre, open-label, single-arm, phase 2 trial
Regimens based on ibrutinib alone and lenalidomide and rituximab in combination show high activity in patients with relapsed or refractory mantle cell lymphoma. We...
Research Insight
Phase 3 PROSPER Trial Shows XTANDI Significantly Reduced the Risk of Metastasis or Death by 71 Percent in Men with Non-Metastatic Castration-Resistant Prostate Cancer
Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) and Pfizer Inc. (NYSE: PFE) announced today results from the Phase 3 PROSPER...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
